The PI3K pathway is upstream of the protein kinase B (Akt) and mammalian target of rapamycin (mTOR) pathways, with PIK3CA mutations and subsequent upregulation of the PI3K pathway common in urothelial carcinoma. Here, AKT1 is linked to urothelial carcinoma.